• ONLY Pharmaceutical Manufacturing Conference in the Middle East
  •  Facility design, technology and construction for the Middle East Region
  •   Investment & partnership opportunities

A rapid increase in population, particularly an expanding middle class demanding better care has attracted global pharmaceutical companies into the Middle East's pharmaceutical market.

The region is now competing with Asia and Latin America countries in terms of production growth rates in local pharma industries. Held on the 23-26 November, Dubai, IBC's Pharma Manufacturing evaluates the pharmaceutical market in the region including evolving regulatory frameworks, investment opportunities, new facilities and technology, quality and distribution.

Manufacturing guidelines and incentives will be examined together with strategies on how companies bring in generics, biosimilars and biologic products through partnership with local manufacturing firms and setting up their own facilities in the region.

Featured Government Speakers

Dr. Tarek Salman
Deputy Minister of Health for Pharmaceutical Affairs
Ministry of Health and Population, Egypt

Dr Amin Al Amiri
Assistant Undersecretary of Public Health Policy & Licensing Sector
Ministry of Health, UAE

Wael Armouti
Legal Affairs Director
Jordan FDA, Jordan

 

Featured Pharma Speakers

Mohamed Fayez Monir
Head of Third Party Manufacturing ( External Supply head for Middle East, Turkey and Africa)
Boehringer Ingelheim International GmbH, UAE
Khaled Ahmed Nasr
Site Director
Arab Company for Pharmaceutical Products (ARABIO), Saudi Arabia
Mohammed Al-Tawil
General Manager & Head of Prescription Medicine
Boehringer Ingelheim, UAE
Osama Nabulsi
Vice President, Business Development and Alliance Management
Hikma Pharmaceuticals PLC, Jordan
Samir A. Khalil
Executive Director, Middle East and Africa
Pharmaceutical Research and Manufacturers of America,
UAE

Ahmed Salah
Technical Director
COPAD Pharma, Egypt

View all speakers »

 

 

Top Reasons to Attend

  • Assess the potential of pharmaceutical markets and healthcare demand in the Middle East
  • Explore key manufacturing projects and overcome regulatory and market challenges
  • Investment and partnership opportunities in key growth areas including UAE, Turkey, Egypt and more
  • Successful market entry and distribution strategy including generics, biosimilar and biologics products
  • Network with and learn from key pharmaceutical players on the ground in the Middle East

 

View full agenda »

 

 

 

Produced bySupporting Association   

 

 
Media Partners